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Although Candida glabrata is an important pathogenic Candida species, relatively little is known about its innate immune rec-
ognition. Here, we explore the potential role of Dectin-2 for host defense against C. glabrata. Dectin-2-deficient (Dectin-2/)
mice were found to be more susceptible to C. glabrata infections, showing a defective fungal clearance in kidneys but not in the
liver. The increased susceptibility to infection was accompanied by lower production of T helper 1 (Th1) and Th17-derived cyto-
kines by splenocytes of Dectin-2/mice, while macrophage-derived cytokines were less affected. These defects were associated
with a moderate yet significant decrease in phagocytosis of the fungus by the Dectin-2/macrophages and neutrophils. Neutro-
phils of Dectin-2/mice also displayed lower production of reactive oxygen species (ROS) upon challenge with opsonized C.
glabrata or C. albicans. This study suggests that Dectin-2 is important in host defense against C. glabrata and provides new in-
sights into the host defense mechanisms against this important fungal pathogen.
The opportunistic fungal pathogen Candida glabrata is the sec-ondmost frequent cause of candidiasis afterCandida albicans,
accounting for approximately 15 to 25% ofCandida infections (1,
2). Similar to other Candida species, C. glabrata resides as a com-
mensal within the normal microbial flora of humans, but it may
also cause serious infections in immunocompromised patients. In
the last 3 decades, the number of infections due to non-albicans
Candida species has increased significantly (3, 4). The current rise
in the incidence of invasive C. glabrata infections is largely the
result of the combinational increase in immunosuppressive infec-
tions and modern prolonged invasive medical interventions (5).
Moreover, C. glabrata is of added concern due to the fact that a
fraction of clinical isolates have been proven to be resistant to
antifungal agents, such as azoles (6). Themortality rate associated
with bloodstream infection withC. glabrata is approximately 50%
in cancer patients and is even higher in bone marrow transplant
patients (7, 8).However, compared to the literature onC. albicans,
few studies have investigated the pathophysiology of C. glabrata
infections, despite its high morbidity and mortality burden.
Pattern recognition of fungal components and activation of
innate immunity are essential steps in the host defense against
Candida species (9). The Candida cell wall is mainly composed of
multiple layers of carbohydrates, such as mannan, -glucan, and
chitin, which are collectively recognized by C-type lectins, includ-
ing macrophage mannose receptor (MR), SIGNR-1, Galectin-3,
Mincle, Dectin-1, Dectin-2, and the Toll-like receptors. This rec-
ognition leads to activation of the host innate immune system.
MR recognizes the N-linked mannans of fungal cell walls,
SIGNR-1 recognizes branched-mannans, and Galectin-3 recog-
nizes -(1,2)-mannans (9–11). It has recently been reported that
Dectin-1 (Clec7a) and Dectin-2 (Clec4n) are specific receptors for
-glucans (12) and C. albicans-derived -mannans (13), respec-
tively.
Dectin-2 is a C-type lectin receptor primarily expressed by
macrophages, dendritic cells and neutrophils, with specificity for
structures rich in mannose (14, 15). Dectin-2 uses the FcR chain
to signal via Syk- and caspase recruitment domain familymember
9 (Card9)-dependent pathways (16–18). It represents an impor-
tant receptor for the generation of the Th17-like adaptive immune
response, coordinating the Th1-like responses together with Dec-
tin-1 (17). Human Dectin-2 has a mannose recognition EPNmo-
tif (15, 19), strengthening the likelihood that Dectin-2 plays an
important role in antifungal immunity. Additionally, Saijo et al.
have reported that Dectin-2 is the functional receptor for -man-
nans and that Dectin-2/ mice are more susceptible to C. albi-
cans (13). However, little is known regarding the specific role of
Dectin-2 for the host defense against C. glabrata.
In this study, we have explored the contribution of Dectin-2 in
the pathophysiology of murine C. glabrata systemic infection.We
show that the burden of C. glabrata was significantly increased in
kidneys of Dectin-2/ mice, which was correlated with a de-
creased phagocytosis and killing of the fungus by the innate im-
mune macrophages (as shown by live-cell video microscopy
phagocytosis assays) and neutrophils (as shown by the ex vivo
phagocytosis and killing assays).Moreover, the adaptive T helper-
derived cytokine responseswere also considerably affected inDec-
tin-2/mice. In conclusion, our data demonstrate an important
role of Dectin-2 for innate immune responses and its signifi-
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cant contribution to the adaptive immune responses against C.
glabrata.
MATERIALS AND METHODS
Generation of Dectin-2/ mice. Dectin-2/ mice were constructed
by Ozgene Pty Ltd., Australia, as described previously (20). Briefly, a
targeting vector was designed to introduce a conditional mutation into
the mouse Clec4n gene (Ensembl version no. ENSMUSG00000023349;
http://www.ensembl.org/Mus_musculus/Gene/Summary?dbcore;g
ENSMUSG00000023349;r6:123229843-123247021). The strategy
utilizes mutant loxP sites (lox66 and lox71) to enable an inversion of the
flanked sequence in response to the expression of Cre recombinase. The
recombination event inactivated the gene by switching the position and
direction of the transcriptional termination (STOP) signal with Clec4n
exon 2. The lox66 site was inserted upstream from Clec4n exon 2, and a
neomycin selection cassette (PGK-Neo) was targeted into the intron be-
tween exon 2 and exon 3. The selection cassette was flanked with FLP
recombination target (FRT) sites to enable removal by FlpE-mediated
recombination. An inverted STOP element and a lox71 site were placed
downstream from the selection marker. The 5= and 3= homology arms of
the vector were approximately 6.1 kb and 5.9 kb, respectively. The target-
ing vector was linearized with PmeI and electroporated into the C57BL/6
embryonal stem (ES) cell line Bruce4. Neomycin-resistant clones were
selected and screened by Southern blotting to identify homologous re-
combinants. Correctly targeted clones were microinjected into BALB/cJ
blastocysts, which were transferred into pseudopregnant CBB6F1 foster
females. Chimeric mice were obtained and outcrossed to C57BL/6J fe-
males to generate ES cell-derived targeted mutant progeny.
Eight- to 12-week-old female Dectin-2/ (Clec4n/) mice on a
C57BL/6J background were obtained from a breeding colony at the Cen-
tral Animal Laboratory, Radboud University Nijmegen Medical Centre.
Age-matched C57BL/6J female mice were obtained from Charles River
Wiga (Sulzfeld, Germany). All mice weighed between 20 and 25 g. The
animals were fed standard laboratory chow (Hope Farms, Woerden, The
Netherlands) and water ad libitum. Most of the experiments were re-
peated at least twice with a minimum of five animals per time point. All
experimentation conformed to the terms and conditions of the Ethics
Committee on Animal Experiments of Radboud University, Nijmegen.
Key experiments, such as for fungal outgrowth and phagocytosis and kill-
ing of C. glabrata, were repeated using Dectin-2/mice generated inde-
pendently, kindly provided by Y. Iwakura (13). These validation studies
were performed at the animal facility of the University of Aberdeen. Live-
cell video microscopy was conducted in Aberdeen; C57BL/6 and Dectin-
2/ (provided by Y. Iwakura) mice were obtained from breeding colo-
nies. All mice were used at 8 to 16 weeks of age. Animals were kept and
handled in accordance with institutional guidelines.
Candida strains, culture media, and growth conditions. C. glabrata
CBS138 (ATCC 2001), a strain described elsewhere (21), was used in all
experiments. C. glabrata was routinely grown and maintained on Sab-
ouraud dextrose plates. For inoculum preparation, a single colony was
grown in Sabouraud dextrose broth at 29°C for 24 h, with shaking. Cells
were washed twice in sterile phosphate-buffered saline (PBS) and counted
using a hemocytometer. Cell density was adjusted with PBS to the desired
inoculum level. C. glabrata was heat killed for 30 min at 95°C. Candida
albicans ATCC MYA-3573 (UC 820) was grown overnight to generate
yeast cells in Sabouraud dextrose broth at 29°C, with shaking. Cells were
harvested by centrifugation, washed twice with PBS, and resuspended in
culture medium (RPMI 1640 Dutch modification). C. albicans yeast was
heat killed for 30 min at 95°C. To generate hyphae, yeast cells were inoc-
ulated and grown overnight at 37°C in culturemedium adjusted to pH 6.4
with hydrochloric acid. Hyphae were killed by exposure to 95°C for 30
min and resuspended in culture medium to a hyphal inoculum size that
originated from 1 108 CFU/ml.
C. glabrata infection model and fungal burden. A nonlethal experi-
mental model of disseminated candidiasis was used, in which wild-type
andDectin-2/micewere injected intravenously, via the lateral tail vein,
with C. glabrata (1  107 CFU/mouse) in a 100 l volume of sterile
pyrogen-free PBS. Mice were monitored daily. For survival studies,
groups of 10 mice were followed-up for a period of 28 days. For immu-
nological and histological studies, subgroups of 5 animals were killed on
day 3, 7, or 14 postinfection. Tissues were collected and processed for
fungal burden and cytokine analysis. To assess the tissue outgrowth of C.
glabrata on these days, the liver and kidneys were removed aseptically,
weighed, and homogenized in sterile PBS in a tissue grinder. The number
of viable Candida cells in the tissues was determined by plating serial
dilutions on Sabouraud dextrose agar plates, as described elsewhere (22).
The CFU were counted after 24 h of incubation at 29°C and expressed as
log CFU per gram of tissue.
Histopathology.Kidney samples from infectedmice were kept in for-
malin until processed. Sections were dehydrated with xylene, rehydrated
through a graded series of ethanol solutions, and stained with hematoxy-
lin and eosin (H&E) or periodic acid-Schiff (PAS) using conventional
stainingmethods. All individual segments were evaluated for the presence
and intensity of inflammation, as well as for the presence of fungi. Tissue
sections were analyzed with a VisionTek digital microscope (Sakura), us-
ing VisionTek Live software.
In vitro cytokine production. Peritoneal macrophages were isolated
from mice by injecting 5 ml of ice-cold sterile PBS (pH 7.4) into the
peritoneal cavity. After centrifugation and washing, cells were resus-
pended in RPMI 1640 culture medium containing 1 mM pyruvate, 2 mM
L-glutamine, and 50 mg/liter gentamicin. Cells were counted using a Z1
Coulter particle counter (Beckman Coulter; Woerden, The Netherlands),
adjusted to 1  106 cells/ml, and cultured in 96-well round-bottom mi-
crotiter plates (Costar, Corning, The Netherlands) at 1 105 cells/well in
a final volume of 200 l. After 24 h of incubation with different stimuli at
37°C and 5%CO2, the plates were centrifuged at 1,400 g for 8 min, and
the supernatants were collected and stored at80°C until cytokine assays
were performed.
Spleen cells were isolated by gently passing spleens through a sterile
200 m filter chamber. After washing with sterile PBS and centrifugation
at 4°C (1,200 rpm for 5min), cells were resuspended in 2ml RPMI 1640 in
the presence of 20% fetal calf serum and counted, and concentrations
were adjusted to 1  107 cells/ml. Cells were cultured in 24-well plates
(Greiner, Alphen a/d Rijn, The Netherlands) at 5  106 cells/well, and
different stimuli were added in a final volume of 1,000 l. Supernatants
were collected at two different time points (depending on the cytokine) as
follows. After 48 h of incubation at 37°C and 5% CO2, 500 l of superna-
tant per well was collected and stored at80°C until cytokine assays were
performed; thereafter, the plates were further incubated at 37°C and 5%
CO2 for an additional 3 days. The plates were centrifuged at 1,400 g for
8 min, and the remaining supernatants were collected and stored at
80°C until cytokine assays were performed. The concentrations of
mouse tumor necrosis factor alpha (TNF-), interleukin-1 (IL-1), and
IL-1were determined by specific radioimmunoassay (RIA).Mouse IL-6,
KC, IL-17, gamma interferon (IFN-), IL-22, and IL-10 concentrations
were measured by commercial enzyme-linked immunosorbent assay
(ELISA) kits (Biosource, Camarillo, CA) according to the instructions of
the manufacturer.
Phagocytosis and killing ofC. glabrata. Peritoneal macrophages and
neutrophils were recruited and phagocytosis and killing assays were per-
formed according to amodification of amethod described elsewhere (23).
C. glabrata/macrophage orC. glabrata/neutrophil ratios of 10:1 were used
in the phagocytosis and killing studies. Peritoneal macrophages or neu-
trophils from groups of 5 C57BL/6J (control) and 5 Dectin-2/ mice
were elicited by an intraperitoneal (i.p.) injection of heat-killed C.
glabrata. Cells were collected in separate sterile tubes either 3 days (mac-
rophages) or 4 h (neutrophils) after C. glabrata infection by washing the
peritoneal cavity with 5 ml of ice-cold PBS. Phagocytes were centrifuged
(for 10 min at 2,250  g), counted in a Bürker counting chamber, and
resuspended in RPMI 1640 Dutchmodification (with 20mMHEPES and
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without L-glutamine; ICN Biomedicals) supplemented with 5% heat-in-
activated fetal calf serum, 1% gentamicin, 1% L-glutamine, and 1% pyru-
vate. The processes of phagocytosis and intracellular killing were studied
in an adherentmonolayer of phagocytes. To create amonolayer of phago-
cytes, 5 105 cells in 100 l of RPMI 1640 were dispensed into the wells
of a 96-well flat-bottom plate (Costar) and incubated at 37°C and 5%
CO2. Macrophages were allowed to adhere for up to 2 h, but neutrophils
for only 30 min before the monolayers were gently washed with culture
medium to remove nonadherent cells. The percentage of adherence was
calculated as follows: (1 [number of nonadherent cells/5 105]) 100.
Subsequently, the cells were incubated with 1  104 CFU C. glabrata,
which were opsonized for 30 min at 24°C in modified Eagle’s medium
(MEM; Gibco Life Technologies) that contained 2.5% freshmouse serum
(effector/target ratio, 40:1). After 15 min, supernatants were aspirated,
andmonolayers were gently washedwithMEM to remove noningestedC.
glabrata. The supernatant and well washings that contained the non-
ingested Candida were combined and plated in serial dilutions on Sab-
ouraud agar plates. The percentage of phagocytosed microorganisms was
defined as follows: [1 (number of uningested CFU/CFU at the start of
incubation)] 100.
The killing of C. glabrata by phagocytes was assessed in the same
monolayers. After removal of the nonphagocytized Candida, 200 l of
culture medium, consisting of Sabouraud in MEM (50%, vol/vol), was
added to themonolayers. After 3 h of incubation at 37°C and 5%CO2, the
wells were gently detached with a cell scraper and washed with 200 l
distilled H2O to achieve lysis of phagocytes. This procedure was repeated
3 times, after which the pooled washes were adjusted to a final volume of
1 ml with distilled water. Microscopic examination of the culture plates
showed that there was an almost complete removal of phagocytes. To
quantify the viable intracellularCandida, 10-fold dilutions of each sample
were spread on Sabouraud agar plates and incubated at 37°C for 24 h. The
percentage of yeast killed by the phagocytes was determined as follows:
[1  (CFU after incubation/number of phagocytized CFU)]  100.
Phagocyte-free incubations of blastoconidiawere included as a control for
yeast viability.
Live-cell video microscopy phagocytosis assays. Standard phagocy-
tosis assays were performed as previously described (24). Briefly, 6 105
live C. glabrata yeasts were added to 2  105 macrophages in -Slide
8-well chambers (ibidi GmbH, Germany) immediately prior to imaging.
Videomicroscopy experiments were performed using an Ultra View VoX
live-cell imaging system (PerkinElmer) with the environmental control
chamber set at 37°C. Images were captured at 1-min intervals for 3 h using
an electron-multiplying charge-coupled device (EMCCD) camera. At
least two independent experimentswere conducted for eachmouse strain,
and twomovies for eachmouse were analyzed (n 7 wild-typemice, and
n  8 Dectin-2/ mice). Volocity 6.2.1 imaging analysis software was
used to trackmacrophagemigration at 1-min intervals for the first 60min
of the phagocytosis assay. The software enabled high-throughput analysis
of macrophage migration, providing detailed information on the dis-
tances traveled and the directionality and velocity of hundreds of individ-
ual macrophages. The data were subsequently displayed in tracking dia-
grams and used to calculate the mean track velocity and track length of
macrophages cultured with C. glabrata. The movies generated for migra-
tion analyses were also analyzed to determine phagocytic uptake at the
30-min, 60-min, and 180-min time points (25). For each mouse, 20 mac-
rophages were analyzed for the percentage of uptake of live C. glabrata
yeasts (calculated by determining the number of macrophages per 100
that had ingested at least one yeast). The phagocytic index was calculated
by counting the total number of yeasts engulfed per hundred macro-
phages at each time point.
Reactive oxygen species (ROS) assay.The spontaneous and stimulus-
induced oxygen radical production levels of isolated neutrophils were
evaluated using luminol-enhanced chemiluminescence and determined
in an automated LB96VMicrolumat plus luminometer (EG&GBerthold,
Bald Wilberg, Germany) as previously described (26). In this study, neu-
trophils (2 105 per well) were seeded into 96-well plates and incubated
in medium containing either RPMI, phorbol 12-myristate 13-acetate
(PMA; 5 g/ml), live opsonized C. albicans (107 CFU/ml) or live op-
sonized C. glabrata (107 CFU/ml). Luminol was added to each well in
order to start the chemiluminescence reaction. Each measurement was
carried out in at least duplicate repetitions. Chemiluminescence was de-
termined every 145 s at 37°C for 1 h. Luminescence was expressed as
relative light units (RLU) per second. Data were analyzed with Winglow
software (EG & Berthold).
Ethics statement. All experiments in this study were carried out in
strict accordancewith the recommendations in theGuide for theCare and
Use of Laboratory Animals of the National Institutes of Health, the Dutch
law on Animal Experiments, and FELASA regulations. The protocol was
approved by the Ethics Committee on Animal Experiments of the Rad-
boud University NijmegenMedical Centre. All efforts were made to min-
imize suffering of the animals. All experiments performed in Aberdeen
conformed to the terms and conditions of United KingdomHome Office
licenses for research on animals and the guidelines of the University of
Aberdeen ethical review committee.
Statistical analysis. Differences in phagocytosis, postphagocytic kill-
ing, and concentrations of cytokineswere analyzed using theMann-Whit-
ney U test. Survival data were analyzed using the Kaplan-Meyer log rank
test. Differences were considered significant at a P value of 	0.05. The
majority of the experiments was performed at least twice, and at least 5
mice/group/time point were used for the outgrowth, phagocytosis, kill-
ing, ROS, and cytokine synthesis experiments. A total of 10 mice/group
were used for survival experiments. Data are presented as means
 stan-
dard errors of the means (SEM).
RESULTS
Increased susceptibility to C. glabrata systemic infection in
Dectin-2/mice. To determine the role of Dectin-2 in the host
defense against C. glabrata, we first compared the susceptibility to
infection of Dectin-2/ and wild-type control mice. Following
infection with C. glabrata, both groups of mice were able to effec-
tively control and eradicate the fungus from the liver within 2
weeks (Fig. 1A). In contrast, while wild-type animals restrained
the infection in their kidneys, significantly higherC. glabrata loads
were observed in Dectin-2/mice (Fig. 1B). Similar increases in
the fungal burdens were observed in the kidneys of the Dectin-
2/mice provided by Y. Iwakura (Fig. 1C). Nonetheless, Dectin-
2/ mice were less susceptible to C. glabrata than has been re-
ported for C. albicans, with no mortality recorded in any of the
mouse strains during the 28 days following intravenous infection
(data not shown). Comparedwith the results for noninfectedmice
(Fig. 2A), histopathological analysis identified zones with lym-
phocytic infiltration suggestive of chronic inflammation in both
wild-type control (Fig. 2B) and Dectin-2/ (Fig. 2C) mice. Spo-
radic neutrophilic granulocytes could be detected (Fig. 2D and E).
At day 7 and day 14 postinfection, the kidneys of Dectin-2/
mice displayed significantly increased numbers of inflammatory
foci compared with the kidneys of wild-type mice. Interestingly,
fungi were only partially associated with inflammation and were
often present in the lumina of tubuli, not in the tissue itself (Fig.
2D and E). Therefore, the foci of chronic, lymphocytic inflamma-
tion were not associated with the presence of fungi. In conclusion,
Dectin-2 appears to be an essential pattern recognition receptor
for the adequate control of C. glabrata renal infection.
Defective Th-associated cytokine production inDectin-2/
mice. To further characterize the role of Dectin-2 for the recogni-
tion of C. glabrata, the ex vivo cytokine profile was assessed in
peritoneal macrophages of naive wild-type and knockout mice.
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Interestingly, the innate response levels from uninfected Dectin-
2/macrophages were slightly higher than the response levels of
the macrophages isolated from the wild-type animals (TNF-,
IL-6, IL-1, and IL-1) (Fig. 3A). Only the IL-6 and KC produc-
tion levels fromDectin-2/macrophages upon stimulation with
C. albicans heat-killed hyphae were lower than the levels from
wild-typemacrophages, although the difference reached statistical
significance only for KC (Fig. 3A). Regarding the T cell-derived
cytokines (IL-10, IFN-, and IL-17) produced by the splenocytes
of uninfected mice, no differences could be detected between the
two groups of mice (Fig. 3B). The IL-17 production levels in the
splenocytes from Dectin-2/mice were highly variable.
FIG 1 Greater C. glabrata loads in the kidneys of mice during systemic infection. (A and B) Quantification of Candida colonies from liver (A) and kidneys (B)
of wild-type (WT) andDectin-2/mice at days 3, 7, and 14 postinfection is shown.Wild-type andDectin-2/mice received 107 CFU ofC. glabrata permouse
intravenously. After 3, 7, and 14 days, organs were collected and serial dilutions were plated on Sabouraud solid medium. Results are means
 SEM (n 10 to
14 mice per group from 3 independent experiments). Significance was determined with the Mann-Whitney U test. Statistically different groups are indicated as
follows: *,P	 0.05; ***,P	 0.001. (C) Fungal burdens in the kidneys ofwild-type andDectin-2/mice provided byY. Iwakura.Wild-type orDectin-2/mice
received 107CFUofC. glabratapermouse intravenously. After 7 days, kidneyswere collected and serial dilutionswere plated on Sabouraud agarmedium.Results
are means
 SEM (n 12 mice per group from two independent experiments). Significance was determined with the Mann-Whitney U test. **, P	 0.01.
FIG 2 Dectin-2 deficiency affects kidney histopathology during systemic infection with C. glabrata. Histopathological assessment of kidneys in uninfected
Dectin-2/ (A), infected wild-type (B), and infected Dectin-2/ (C) (hematoxylin-and-eosin [H&E]-stained sections) and infected Dectin-2/ (D and E)
(periodic acid-Schiff [PAS]-stained sections)mice. Representative localized lesions andC. glabrata colonies in the kidneys of Dectin-2/mice are shown (C, D,
and E). All observations of infected kidneys were performed at day 14 after intravenous injection with C. glabrata.
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In a subsequent set of experiments, we studied the ex vivo cy-
tokine responses of peritoneal macrophages and splenocytes iso-
lated from mice infected with C. glabrata. No differences were
detectable between the two groups of mice in most of the macro-
phage-derived cytokines assayed (intracellular/extracellular IL-1
and IL-1 and extracellular production of IL-6 and KC; data not
shown), with the exception of TNF- at day 14 postinfection (Fig.
4A). Similar to the results for peritoneal macrophages, ex vivo
stimulation of splenocytes fromC. glabrata-infectedmice resulted
in significantly lower levels of TNF- production by Dectin-2/-
deficient cells upon stimulationwith eitherC. glabrata (Fig. 4B) or
C. albicans (Fig. 4C), although dissimilarities were detectable ear-
lier in the course of the infection. No significant differences could
be detected in the amounts of the anti-inflammatory cytokine
IL-10 produced by either strain. In addition to the responses of the
innate cytokines, Th1 and Th17 responses at 7 days postinfection
were also significantly reduced in Dectin-2/ splenocytes, as
mirrored by the low production of IFN- and IL-17 (Fig. 4B). The
levels of IL-22 were moderately reduced at day 14 postinfection
(Fig. 4B). A similar patternwithmore pronounced differenceswas
observed when splenocytes from infected mice were restimulated
with C. albicans yeast (Fig. 4C). As such, Dectin-2 deficiency re-
sults in decreased production of protective T helper-derived cyto-
kines.
Dectin-2/ peritoneal macrophages are less efficient in the
uptake and killing of C. glabrata ex vivo. The phagocytic clear-
ance of microorganisms, including yeasts, by professional phago-
cytes ismediated by receptor activation that drives the engulfment
and internalization of the pathogen. We therefore assessed the
ability of Dectin-2/ peritoneal macrophages to recognize,
phagocytose, and kill live opsonized C. glabrata. Using a classical
ex vivo phagocytosis and killing assay (23), wild-type peritoneal
macrophages were found to be slightly more efficient in the
phagocytosis and subsequent killing of C. glabrata than Dectin-
2/ macrophages (Fig. 5A). We further investigated the migra-
tion of peritoneal macrophages toward C. glabrata by live-cell
videomicroscopy using a phagocytosis assay described previously
(25). Dynamic analysis of individual macrophages, achieved by
tracking cells to determine their directionality, distance, and ve-
locity for the first hour of the assay, demonstrated no major dif-
ferences in migration dynamics between macrophages harvested
fromwild-type or Dectin-2/ animals (Fig. 5B). However, in the
same experiment, a complementary analysis revealed a significant
difference between the two types of macrophages in terms of the
uptake and phagocytosis of live C. glabrata. Following 30 min of
coincubation with live C. glabrata, 51% of the wild-type macro-
phages had ingested at least one yeast, whereas Dectin-2/mac-
rophages showed a significantly reduced uptake of 34% (Fig. 5C).
This significantly reduced uptake capacity was noticeable early
during the phagocytosis assay (30 min and 60 min) but not at a
later time point (180 min) (Fig. 5C). Additionally, the total num-
bers of fungal cells phagocytosed by macrophages from Dectin-
2/mice were also significantly lower than the numbers phago-
cytosed by wild-type macrophages at 30 min and 60 min of
coincubation (Fig. 5D). Altogether, these results highlight a par-
tial, yet significant role of Dectin-2 in mediating the uptake and
FIG 3 Cytokine profile from naive mice. Cells from naive mice were stimulated for 24 h (peritoneal macrophages) (A) or for 48 h and 5 days (splenocytes) (B)
with heat-killed (HK) or live C. glabrata (Cg), heat-killed C. albicans yeast (Cay) or hyphae (Cah), and live C. albicans (Ca). Levels of TNF-, IL-6, KC, IL-1,
IL-1, IL-10, IFN-, and IL-17 accumulation were measured by ELISA. Results are means
 SEM (n 8mice per group). Significance was determined with the
Mann-Whitney U test. Statistically different groups are indicated as follows: *, P	 0.05; **, P	 0.01.
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engulfment of C. glabrata by macrophages. In addition, partial
effects on fungal killing may also be envisioned, although more
studies should be performed to establish that definitively.
Dectin-2/ neutrophils are less efficient in phagocytosing
and killing C. glabrata ex vivo.We next assessed the recognition
and killing of C. glabrata by neutrophils, pivotal players in the
clearance of invading fungal cells from tissues. Neutrophils were
harvested from the peritoneal cavity of bothwild-type andDectin-
2/ mice and further subjected to an ex vivo phagocytosis and
killing assay (23). The phagocytosis of C. glabrata by the Dectin-
FIG 4 Dectin-2 is required during systemic C. glabrata infection for subsequent splenocyte recall responses. Wild-type or Dectin-2/mice received 107 CFU
ofC. glabrata permouse intravenously. (A) After 3, 7, and 14 days, peritonealmacrophages were restimulated ex vivowith heat-killedC. glabrata (Cg), heat-killed
C. albicans yeast (Cay), or hyphae (Cah) for 24 h. Levels of TNF- accumulation in the supernatants were measured by ELISA. Results are means
 SEM (n
9 or 10mice per group) from 2 independent experiments. Significance was determinedwith theMann-WhitneyU test. Statistically different groups are indicated
as follows: *, P	 0.05. (B and C) Wild-type or Dectin-2/mice received 107 CFU of C. glabrata per mouse intravenously. After 3, 7, and 14 days, splenocytes
were restimulated ex vivo with either heat-killed C. glabrata (B) or heat-killed C. albicans yeast (C) for 48 h and 5 days. Levels of accumulation of TNF-, IL-10,
and IFN- (48 h) and of IL-17 and IL-22 (5 days) in the supernatants were measured by ELISA. Results are means
 SEM (n 14 or 15 mice per group) from
3 independent experiments. Significancewas determinedwith theMann-WhitneyU test. Statistically different groups are indicated as follows: *,P	 0.05; **,P	
0.01; ***, P	 0.001.
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2/ neutrophils was considerably less effective than the phago-
cytosis of C. glabrata by neutrophils of wild-type mice (Fig. 6A).
The killing of C. glabrata by the Dectin-2/ neutrophils was
slightly diminished compared with the killing by control neutro-
phils (Fig. 6A). Importantly, neutrophils from Dectin-2/mice
showed a defect in secretion of ROS upon interaction with either
live opsonized C. glabrata or C. albicans compared with the ROS
secretion of wild-type neutrophils (Fig. 6B). Interestingly, the de-
FIG 5 Impact of Dectin-2 deficiency on phagocytosis and killing of C. glabrata by peritoneal macrophages. (A) Phagocytosis and killing of C. glabrata cells by
murine peritonealmacrophages. The results are represented as percentage of phagocytosis (the percentage of fungal cells engulfed bymacrophages present in the
well) and percentage of killing (the percentage of killed fungal cells among the phagocytosed yeasts). TheC. glabrata/macrophage ratio was 10:1. Significance was
determined with the Mann-Whitney U test. Values represent means
 SEM (n 5 mice per group). (B) Migration of peritoneal macrophages was determined
using live-cell video microscopy. Tracking diagrams illustrate the distances traveled and the directionality and velocity of macrophages exposed to C. glabrata at
a fungal particle/macrophage ratio of 3:1. Due to the large number of macrophages tracked per video, the data were filtered to show only macrophages whose
tracks lasted until 30 min to 60 min, as previous work has shown that migration activity is greater early on (25). Tracks represent the movement of individual
macrophages relative to their starting position, symbols indicate the location of macrophages at 1-min intervals, and arrows represent directionality. (n  7
control mice and n  8 Dectin-2/ mice for 4 independent experiments). (C and D) Percentage of uptake (C) and phagocytic index (D) determined using
live-cell video microscopy. The percentage of macrophages that have ingested at least one C. glabrata and the number of C. glabrata per 100 macrophages are
depicted. Significance was determined with the Mann-Whitney U test. Values represent means
 SEM. *, P	 0.05.
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fect was specific for fungi, as no differences in ROS production
were observed when cells were stimulated with PMA (Fig. 6B).
Thus, Dectin-2 is important in both the uptake of C. glabrata by
neutrophils and the subsequent ROS production and killing of the
yeast.
DISCUSSION
Dectin-2 is one of the main pattern recognition receptors for fun-
galmannans, with recent studies demonstrating an important role
for this receptor in host defense against C. albicans (13). In the
present study, we show that Dectin-2 is also an important compo-
nent of the host defense againstC. glabrata. The increased suscep-
tibility of Dectin-2/ mice to a systemic infection with C.
glabrata is associated with a combination of decreased production
of protective T helper-derived cytokines and defective phagocyto-
sis and killing of the yeast by both neutrophils and macrophages.
Little is known of the role of the C-type lectin receptor, Dec-
tin-2. A recent study reported that Dectin-2/ mice are highly
susceptible to a systemic infection with C. albicans (13). More-
over, it has been shown that Dectin-2 plays an important role in
the induction of protective Th17 responses (17) and that, together
withDectin-3, it forms a heterodimeric pattern recognition recep-
tor for host defense against C. albicans (27). The intracellular sig-
naling induced by Dectin-2 involves activation of CARD9 (28),
phospholipase C- (29), and protein kinase C- (30). Our study
demonstrates that Dectin-2 has a nonredundant role for host de-
fense against C. glabrata. This is an important observation not
only for our improved understanding of C. glabrata infection but
also for Dectin-2 biology: while Dectin-2 has been suggested to
recognize mainly C. albicans hyphae (13), its importance for rec-
ognition of a Candida species that does not usually develop hy-
phae is a broadening of the biological importance ofDectin-2. The
increased susceptibility to C. glabrata was demonstrated in two
independently generated groups of Dectin-2/mice, reinforcing
this conclusion. However, these mice were less susceptible to C.
glabrata than toC. albicans, as reported earlier (13). The increased
susceptibility of Dectin-2/ mice to C. glabrata was apparent
through their incapacity to eliminate the fungus from the kidneys,
the target organ of disseminated candidiasis (31). Previously re-
ported studies already showed that systemic candidiasis increased
the fungal burden in kidneys of Dectin-1/mice compared with
the fungal burden in kidneys of the wild-type mice (12). The fact
that the animalswere able to eradicateC. glabrata from the liver, in
comparison with the results for the kidneys, confirms recent find-
ings concerning organ-specific Candida infection and immune
responses mediated primarily by neutrophils and monocytes, as
well as by various molecular factors (32–34).
Fungal pathogens have developed a number of strategies to
improve their chance of survival in the host environment; e.g., C.
albicans andCryptococcus neoformans either destroy macrophages
or escape via nonlytic exocytosis (35, 36). Interestingly,C. glabrata
engulfed bymacrophages does not undergo amorphological tran-
sition but survives and multiplies within mammalian macro-
phages (37, 38), which are ultimately damaged by ingested C.
glabrata (38). In our study, we assessed the role of Dectin-2 for the
phagocytosis and killing of C. glabrata and observed that neutro-
phils and macrophages lacking this receptor were less capable of
ingesting and killing the yeast. Using live-cell video microscopy,
we found that significantly fewer Dectin-2/macrophages took
upC. glabrata, in accordance with a lower phagocytic index where
phagocytosis had occurred. These defects in the uptake and
phagocytosis of C. glabrata could not be attributed to a defect in
mobility. Finally, signaling through C-type lectin receptors in-
duces cytokines and ROS that both activate the spleen tyrosine
kinase (Syk)–CARD9–nuclear factor-B (NF-B) pathway (39)
and, most likely, induce the intraphagosomal damage of fungal
cells. In line with a role of the CARD9 pathway, Drewniak et al.
showed that human CARD9 deficiency resulted in a selective de-
fect in the host defense against invasive fungal infection, caused by
impaired phagocyte killing in unopsonized samples compared
with the phagocyte killing in opsonized samples (40). In the pres-
ent study, Dectin-2/ neutrophils produced less ROS than wild-
type neutrophils after stimulation of cells with either opsonizedC.
glabrata or C. albicans, suggesting a role of Dectin-2 in the killing
of Candida species despite the presence of opsonins.
The induction of proinflammatory cytokines is an important
component of anti-Candida host defense. Macrophage-derived
proinflammatory cytokines like IL-1, KC, or IL-6 activate the re-
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FIG 6 Impact of Dectin-2 deficiency on phagocytosis and killing of C. glabrata by neutrophils. (A) Phagocytosis and killing of C. glabrata cells by murine
neutrophils. The results are represented as percentage of phagocytosis (the percentage of fungal cells engulfed by neutrophils present in the well) and percentage
of killing (the percentage of killed fungal cells among the phagocytosed yeast). The C. glabrata/neutrophil ratio was 10:1. Values represent means
 SEM (n
10mice per group) for 2 independent experiments. P values are for phagocytosis or killing induced by wild-type and Dectin-2/macrophages. *, P	 0.05. (B)
Dectin-2/ neutrophils cannot induce the respiratory burst to the same extent as the wild type. Dectin-2/ or wild-type neutrophils were stimulated with
RPMI, phorbol 12-myristate 13-acetate (PMA), live opsonized C. glabrata, or live opsonized C. albicans, and overall oxygen radical production (area under the
curve after 60 min) was measured with luminol-enhanced chemiluminescence in isolated neutrophils. Data are represented as means
 SEM (n 10 mice per
group) for 2 independent experiments. Significance was determined with theMann-Whitney U test. Statistically different groups are indicated as follows: *, P	
0.05; ***, P	 0.001.
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cruitment of phagocytes and the phagocytosis and killing of fungi
by phagocytes, and mice deficient in these cytokines have an in-
creased susceptibility to systemic candidiasis (41, 42). No major
defects in the production of these cytokines were observed in cells
isolated from Candida-challenged Dectin-2/mice. In contrast,
the secretion of cytokines produced by Th1 and Th17 lympho-
cyteswas significantly decreased inDectin-2/mice. IFN- is the
main product of Th1 lymphocytes, and it has been proven to have
a crucial role in antifungal host defense inmice (43). The defective
production of IFN- by splenocytes of Dectin-2/ mice may
represent one of the mechanisms determining the increased sus-
ceptibility to C. glabrata in these mice. Similarly, the Th17 cyto-
kine, IL-17, represents an important component of antifungal
host defense through its activation of neutrophils (44), while
patients with defective Th17 responses develop chronic mucocu-
taneous candidiasis (45). The level of IL-17 produced by Dectin-
2/ splenocytes was significantly decreased at day 7 postinfection,
suggesting a role for Dectin-2 in regulating splenocyte recall re-
sponses to fungal infection. The defective Th17 responses in Dectin-
2/ mice could therefore contribute to their susceptibility to C.
glabrata. These results underline the conclusions of Saijo et al. (13)
concerning Dectin-2-mediated immunity to C. albicans. The
IL-17 defect in response to C. glabrata observed in our study was,
however, less pronounced than that previously reported for C.
albicans (13). Moreover, we should observe that the cytokine dif-
ferences were most pronounced earlier during infection. At later
time points during the infection, the picture starts to be biased by
the higher fungal burden in the KOmice, which may counterbal-
ance the defective cytokine production capacity.
The known fungal ligands recognized by Dectin-2 are -man-
nans (13).Whereas significant research has been conducted on the
structure of theC. albicans cell wall, much less is known regarding
the cell wall components ofC. glabrata.While recognition ofman-
nans of C. glabrata by Dectin-2 is most likely, future studies
should define the precise ligand-receptor interaction profile, es-
pecially asC. glabrata is less likely to form hyphae thanC. albicans.
Moreover, both endogenous (T cell) and exogenous (microbial
carbohydrate) ligands for Dectin-2 may be important for the gen-
eration andmaintenance of tolerance or the recognition of carbo-
hydrate structures. Of particular interest is that previous reports
have highlighted the ability of Dectin-2 to specifically signal after
recognition of the hyphal form ofC. albicans (28). The interaction
between C. glabrata and Dectin-2 is different, as C. glabrata does
not form traditional compartmentalized hyphae. Still, previous
reports have described tubes and pseudohypha formation in sev-
eral clinical isolates of C. glabrata (46), and these might be recog-
nized by Dectin-2.
In conclusion, we demonstrate that the immune responses
triggered by Dectin-2 during infection withC. glabratamight link
innate immune recognition, phagocytosis, and killing of the fun-
gus with the adaptive T helper-dependent responses. A combina-
tion of these mechanisms controls C. glabrata during systemic
infection. Deciphering the precise mechanisms responsible for
host defense against C. glabrata represents an important step in
understanding of the pathophysiology of the disease and for the
possibility to design future novel immunotherapeutic strategies.
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